Studies spread of colon cancer to the right gastroepiploic mesentery
Observes colon cancer near the hepatic flexure and tests surgery removing the right gastroepiploic mesentery.
Plain-language title generated from the registry record
Registry title: Mesogastrium Metastasis in Colon Cancer
Key facts
- Where
- Wuhan, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with colon cancer at or near the hepatic flexure who are having complete mesocolic excision surgery with right gastric mesentery resection.
- Age
- 18 to 75 years
- Sex
- All sexes can join.
- Disease stage
- Biopsy-proven colorectal carcinoma. Staging before surgery cT2-4aN0M0 or cTanyN+M0. Tumor at the hepatic flexure or at the transverse colon close to the flexures.
- Earlier treatment
- Must be having complete mesocolic excision with right gastric mesentery resection.
Main reasons for not taking part
- Another colorectal cancer at the same time
- Signs of metastasis
- Earlier colorectal cancer or other malignant tumors
- Staging before surgery cT1N0 or cT4bNany
- Emergency procedure
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT04980287, who can take part
Where in China
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & TechnologyWuhan, ChinaContact: jichao qin, M.D./Ph.DTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Jichao Qin
- Trial code
- NCT04980287
- Record updated
- 15 October 2026
- Original description
Complete mesocolic excision is currently recognized as a standard procedure for colon cancer. Controversy remains on the presence of right gastroepiploic mesentery metastasis in patients with colon cancer locating at or close to the hepatic flexure. The investigators design this study in order to define the incidence of mesogastrium metastasis and analyse the safety and surgical outcome in these patients who undergo complete mesocolic excision with right gastroepiploic mesentery resection.Read full original descriptionShow less
Right Gastroepiploic Mesentery Metastasis in Advanced Colon Cancer Locating at or Close to the Hepatic Flexure
Complete mesocolic excision is currently recognized as a standard procedure for colon cancer. Controversy remains on the presence of right gastroepiploic mesentery metastasis in patients with colon cancer locating at or close to the hepatic flexure. The investigators design this study in order to define the incidence of mesogastrium metastasis and analyse the safety and surgical outcome in these patients who undergo complete mesocolic excision with right gastroepiploic mesentery resection.
Inclusion: Age between 18 and 75 years; American Society of Anesthesiologists (ASA) score I to III; A biopsy proven histological diagnosis of colorectal carcinoma; Preoperative staging cT2-4aN0M0 or cTanyN+M0; tumor located at hepatic flexure or transverse colon close to flexures; Undergoing complete mesocolic excision with right gastric mesentery resection; Patients have to be aware of the aim of the trial, and have signed the informed consent.
Exclusion: History of colorectal cancer or other malignant tumors; Synchronous colorectal carcinoma; Clinical evidence of metastasis; Preoperative staging cT1N0 or cT4bNany; Emergency procedure.